Physician profile
David S Caminear
NPI 1841287091
$47,242.05
in general payments reported to CMS, 2019-2025
20 companies · $278 in 2025
The $278 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $23K · 2020: $5,878 · 2021: $4,501 · 2022: $5,234 · 2023: $7,857 · 2024: $982 · 2025: $278.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $7,250 · Food and Beverage: $914 · Royalty Or License: $596 · Travel and Lodging: $358.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $7,250.00 |
| Food and Beverage | $913.78 |
| Royalty Or License | $596.20 |
| Travel and Lodging | $357.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gramercy Extremity Orthopedics LLC | $27,524.46 | 2019-2025 | |
| Synthes USA Products LLC | $9,446.49 | 2019 | |
| Trimed, INC. | $3,160.02 | 2019 | |
| Medical Device Business Services, INC. | $2,181.93 | 2019 | |
| Stryker Corporation | $1,891.84 | 2019-2025 | Variax, Valor, Infinity Adaptis |
| Orthofix Medical, INC. | $1,535.58 | 2019-2025 | Physio-Stim |
| International Life Sciences | $357.80 | 2023 | |
| Smith+Nephew, INC. | $277.27 | 2022-2024 | Panta 2, Vlp Mini-Mod, Cadence |
| Depuy Synthes Sales INC. | $210.12 | 2019-2021 | |
| Kowa Pharmaceuticals America, INC. | $130.20 | 2023 | Seglentis |
| Osiris Therapeutics INC. | $115.73 | 2019 | |
| Polaris Technology Solutions LLC | $92.30 | 2024 | |
| Treace Medical Concepts, INC. | $90.68 | 2023 | |
| Boston Scientific Corporation | $74.29 | 2023 | |
| Bioventus LLC | $45.70 | 2025 | Xcell, Exogen Ultrasound Bone Healing System |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vericel Corporation | $26.00 | 2023 | Maci |
| Axogen | $24.35 | 2022 | |
| Horizon Therapeutics Plc | $24.18 | 2019-2020 | |
| Innovation Technologies INC | $17.18 | 2025 | Irrisept |
| Fusion Orthopedics USA, LLC | $15.93 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Caminear listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.